Literature DB >> 28154090

Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease.

Walter Spindelboeck1,2, Eduard Schulz3, Barbara Uhl3, Karl Kashofer4, Ariane Aigelsreiter4, Wilma Zinke-Cerwenka3, Adnan Mulabecirovic3, Patrizia K Kump1,2, Bettina Halwachs2,3,4, Gregor Gorkiewicz2,3,4, Heinz Sill3, Hildegard Greinix3, Christoph Högenauer5,2, Peter Neumeister6.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28154090      PMCID： PMC5477627          DOI： 10.3324/haematol.2016.154351

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  16 in total

1.  Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut.

Authors:  Kazuhiko Kakihana; Yuki Fujioka; Wataru Suda; Yuho Najima; Go Kuwata; Satoshi Sasajima; Iyo Mimura; Hidetoshi Morita; Daisuke Sugiyama; Hiroyoshi Nishikawa; Masahira Hattori; Yutaro Hino; Shuntaro Ikegawa; Keita Yamamoto; Takashi Toya; Noriko Doki; Koichi Koizumi; Kenya Honda; Kazuteru Ohashi
Journal:  Blood       Date:  2016-07-26       Impact factor: 22.113

2.  What predicts high risk acute graft-versus-host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score.

Authors:  Margaret L MacMillan; Todd E DeFor; Daniel J Weisdorf
Journal:  Br J Haematol       Date:  2012-04-06       Impact factor: 6.998

Review 3.  First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.

Authors:  Paul J Martin; J Douglas Rizzo; John R Wingard; Karen Ballen; Peter T Curtin; Corey Cutler; Mark R Litzow; Yago Nieto; Bipin N Savani; Jeffrey R Schriber; Paul J Shaughnessy; Donna A Wall; Paul A Carpenter
Journal:  Biol Blood Marrow Transplant       Date:  2012-04-14       Impact factor: 5.742

4.  Duodenal infusion of donor feces for recurrent Clostridium difficile.

Authors:  Els van Nood; Anne Vrieze; Max Nieuwdorp; Susana Fuentes; Erwin G Zoetendal; Willem M de Vos; Caroline E Visser; Ed J Kuijper; Joep F W M Bartelsman; Jan G P Tijssen; Peter Speelman; Marcel G W Dijkgraaf; Josbert J Keller
Journal:  N Engl J Med       Date:  2013-01-16       Impact factor: 91.245

5.  Current practice in diagnosis and treatment of acute graft-versus-host disease: results from a survey among German-Austrian-Swiss hematopoietic stem cell transplant centers.

Authors:  Daniel Wolff; Francis Ayuk; Ahmet Elmaagacli; Hartmut Bertz; Anita Lawitschka; Michael Schleuning; Ralf-Georg Meyer; Armin Gerbitz; Inken Hilgendorf; Gerhard C Hildebrandt; Matthias Edinger; Stephan Klein; Jörg Halter; Sabine Mousset; Ernst Holler; Hildegard T Greinix
Journal:  Biol Blood Marrow Transplant       Date:  2013-01-29       Impact factor: 5.742

Review 6.  Infectious complications of stem cell transplantation.

Authors:  Charulata Ramaprasad; Kenneth J Pursell
Journal:  Cancer Treat Res       Date:  2014

7.  Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation.

Authors:  Robert R Jenq; Carles Ubeda; Ying Taur; Clarissa C Menezes; Raya Khanin; Jarrod A Dudakov; Chen Liu; Mallory L West; Natalie V Singer; Michele J Equinda; Asia Gobourne; Lauren Lipuma; Lauren F Young; Odette M Smith; Arnab Ghosh; Alan M Hanash; Jenna D Goldberg; Kazutoshi Aoyama; Bruce R Blazar; Eric G Pamer; Marcel R M van den Brink
Journal:  J Exp Med       Date:  2012-04-30       Impact factor: 14.307

8.  Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection.

Authors:  Yang Song; Shashank Garg; Mohit Girotra; Cynthia Maddox; Erik C von Rosenvinge; Anand Dutta; Sudhir Dutta; W Florian Fricke
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

9.  Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation.

Authors:  C Castilla-Llorente; P J Martin; G B McDonald; B E Storer; F R Appelbaum; H J Deeg; M Mielcarek; H Shulman; R Storb; R A Nash
Journal:  Bone Marrow Transplant       Date:  2014-04-28       Impact factor: 5.483

10.  Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease.

Authors:  Nathan D Mathewson; Robert Jenq; Anna V Mathew; Mark Koenigsknecht; Alan Hanash; Vincent B Young; Subramaniam Pennathur; Marcel van den Brink; Tomomi Toubai; Katherine Oravecz-Wilson; Shin-Rong Wu; Yaping Sun; Corinne Rossi; Hideaki Fujiwara; Jaeman Byun; Yusuke Shono; Caroline Lindemans; Marco Calafiore; Thomas M Schmidt; Kenya Honda; Pavan Reddy
Journal:  Nat Immunol       Date:  2016-03-21       Impact factor: 25.606
View more
  51 in total

Review 1.  New and emerging therapies for acute and chronic graft versus host disease.

Authors:  LaQuisa Hill; Amin Alousi; Partow Kebriaei; Rohtesh Mehta; Katayoun Rezvani; Elizabeth Shpall
Journal:  Ther Adv Hematol       Date:  2017-11-28

Review 2.  Recipient factors in faecal microbiota transplantation: one stool does not fit all.

Authors:  Camille Danne; Nathalie Rolhion; Harry Sokol
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-04-27       Impact factor: 46.802

3.  Fecal microbiota transplantation with frozen capsules for a patient with refractory acute gut graft-versus-host disease.

Authors:  Satoshi Kaito; Takashi Toya; Kota Yoshifuji; Shuhei Kurosawa; Kyoko Inamoto; Kozue Takeshita; Wataru Suda; Kazuhiko Kakihana; Kenya Honda; Masahira Hattori; Kazuteru Ohashi
Journal:  Blood Adv       Date:  2018-11-27

4.  Empiric antibiotic use in allogeneic hematopoietic cell transplantation: should we avoid anaerobe coverage?

Authors:  Yusuke Shono; Marcel R M van den Brink
Journal:  Blood Adv       Date:  2017-11-17

5.  Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.

Authors:  Zachariah DeFilipp; Jonathan U Peled; Shuli Li; Jasmin Mahabamunuge; Zeina Dagher; Ann E Slingerland; Candice Del Rio; Betsy Valles; Maria E Kempner; Melissa Smith; Jami Brown; Bimalangshu R Dey; Areej El-Jawahri; Steven L McAfee; Thomas R Spitzer; Karen K Ballen; Anthony D Sung; Tara E Dalton; Julia A Messina; Katja Dettmer; Gerhard Liebisch; Peter Oefner; Ying Taur; Eric G Pamer; Ernst Holler; Michael K Mansour; Marcel R M van den Brink; Elizabeth Hohmann; Robert R Jenq; Yi-Bin Chen
Journal:  Blood Adv       Date:  2018-04-10

Review 6.  The gut microbiota and graft-versus-host disease.

Authors:  David N Fredricks
Journal:  J Clin Invest       Date:  2019-05-01       Impact factor: 14.808

7.  Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Authors:  Zev H Davidovics; Sonia Michail; Maribeth R Nicholson; Larry K Kociolek; Nikhil Pai; Richard Hansen; Tobias Schwerd; Aldo Maspons; Raanan Shamir; Hania Szajewska; Nikhil Thapar; Tim de Meij; Alexis Mosca; Yvan Vandenplas; Stacy A Kahn; Richard Kellermayer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-01       Impact factor: 2.839

Review 8.  The Gut Microbiota and Hematopoietic Stem Cell Transplantation: Challenges and Potentials.

Authors:  Fozia Noor; Anne Kaysen; Paul Wilmes; Jochen G Schneider
Journal:  J Innate Immun       Date:  2018-10-04       Impact factor: 7.349

Review 9.  Allogenic stem cell transplant-associated acute graft versus host disease: a computational drug discovery text mining approach using oral and gut microbiome signatures.

Authors:  M F Beckman; D S Morton; F Bahrani Mougeot; J-L C Mougeot
Journal:  Support Care Cancer       Date:  2020-10-22       Impact factor: 3.603

10.  Butyrogenic bacteria after acute graft-versus-host disease (GVHD) are associated with the development of steroid-refractory GVHD.

Authors:  Jonathan L Golob; Martha M DeMeules; Tillie Loeffelholz; Z Z Quinn; Michael K Dame; Sabrina S Silvestri; Michael C Wu; Thomas M Schmidt; Tina L Fiedler; Matthew J Hoostal; Marco Mielcarek; Jason Spence; Steven A Pergam; David N Fredricks
Journal:  Blood Adv       Date:  2019-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.